+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Porcine Kidney Cells Market by Biomedical Research, Pharmaceutical Production, Veterinary Medicine, Toxicology Testing, Technological Advancements - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030- Product Image
Porcine Kidney Cells Market by Biomedical Research, Pharmaceutical Production, Veterinary Medicine, Toxicology Testing, Technological Advancements - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030- Product Image
New

Porcine Kidney Cells Market by Biomedical Research, Pharmaceutical Production, Veterinary Medicine, Toxicology Testing, Technological Advancements - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030

  • PDF Icon

    Report

  • 188 Pages
  • August 2025
  • Region: Global, United States
  • 360iResearch™
  • ID: 6153051
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Introduction: Emerging Frontiers in Porcine Kidney Cell Research

The field of porcine kidney cell research is experiencing an unprecedented convergence of scientific innovation, regulatory shifts, and market dynamics. Fueled by the need for more accurate disease models, safer drug screening platforms, and scalable biomanufacturing processes, researchers and industry leaders are leveraging the anatomical similarities between porcine and human kidneys to accelerate translational breakthroughs. This executive summary outlines the critical drivers, emerging trends, and strategic considerations shaping the porcine kidney cell landscape. By examining transformative shifts, tariff implications, segmentation nuances, regional variances, and leading corporate strategies, this report equips decision-makers with the insights required to navigate complexity and seize opportunities. Ultimately, the synthesis of these factors will determine how effectively stakeholders can optimize protocols, align investments, and advance both clinical and commercial applications.

Transformative Shifts Reshaping the Porcine Kidney Cell Landscape

Over the past decade, technological breakthroughs have redefined the porcine kidney cell arena. Innovations in three-dimensional culture models and co-culture systems now enable more physiologically relevant tissue constructs, bridging the gap between in vitro assays and in vivo outcomes. Concurrently, automation integration and bioreactor design enhancements have scaled production capacities, ensuring consistent cell quality and reproducibility. On the regulatory front, evolving guidelines for xenotransplantation research and advanced therapy medicinal products have prompted organizations to adopt more robust risk assessment procedures and dose optimization methods. Moreover, the growing emphasis on nephrotoxicity studies within preclinical safety profiling has elevated the demand for highly standardized cell platforms. These transformative shifts-powered by cross-disciplinary collaboration, digital process controls, and advanced analytics-are propelling the field toward higher fidelity models and streamlined workflows, thereby accelerating the translation of porcine kidney cell innovations from bench to bedside.

Assessing the Cumulative Impact of 2025 U.S. Tariffs on Industry Dynamics

In 2025, the imposition of new U.S. tariffs on imported biological reagents, consumables, and porcine-derived intermediates introduced both cost pressures and strategic realignments across the value chain. Raw material expenses for antibody production and biological compound synthesis have risen, compelling manufacturers to renegotiate supplier contracts and explore in-house sourcing alternatives. Parallel increases in equipment duties have impacted investments in automation systems and bioreactor technologies, leading to deferred capital expenditures in some laboratories. These shifts have also spurred greater interest in regional sourcing within the Americas to mitigate exposure to cross-border levies. At the same time, contract research organizations specializing in nephrotoxicity studies and disease modeling have recalibrated pricing structures to maintain margins without compromising quality. While short-term disruption was evident, the heightened focus on supply-chain resiliency and localization is fostering stronger partnerships and vertical integration strategies that promise sustainable cost management and operational agility.

Key Segmentation Insights Driving Targeted Strategies

A granular analysis of market segmentation reveals distinct growth vectors and strategic imperatives. From the lens of biomedical research, the porcine kidney cell sector spans disease modeling, drug discovery and development, and nephrotoxicity studies, with experimental protocol optimization driving greater assay reliability and throughput. In pharmaceutical production, the focus shifts to antibody production, biological compound synthesis, and vaccination development, underscoring the critical role of high-yield bioprocessing platforms. Veterinary medicine applications layer on a dimension of animal health diagnostics, regenerative research, and advances in xenotransplantation research, highlighting the translational potential for both human and animal therapeutics. Toxicology testing relies on chemical exposure analysis, risk assessment procedures, and safety profiling, where dose optimization methods refine study designs for enhanced predictive accuracy. Finally, technological advancements permeate every segment, as automation integration streamlines manual workflows, bioreactor innovation maximizes culture scalability, and sophisticated cell culture techniques-especially three-dimensional models and complex co-culture systems-elevate functional relevance and mimicry of native renal microenvironments.

Key Regional Insights Across Americas, EMEA, and Asia-Pacific

Regional demand patterns for porcine kidney cell applications reveal divergent priorities and investment philosophies. In the Americas, robust funding for regenerative research and xenotransplantation studies is fueling expansion in contract research services and specialized cell manufacturing facilities, while a well-established pharmaceutical ecosystem accelerates vaccine development initiatives. Europe, the Middle East & Africa present a mosaic of regulatory harmonization efforts and academic-industrial partnerships, with heightened emphasis on nephrotoxicity assays and standardized safety profiling protocols to align with stringent EU and GCC guidelines. Across Asia-Pacific, rapid biopharmaceutical growth, cost-effective manufacturing hubs, and strong government support for biotechnology innovation are driving adoption of automation integration and bioreactor advancements, particularly in China, South Korea, and Australia. Collectively, these regional nuances underscore the importance of adapting go-to-market approaches, optimizing supply chains for localized content, and forging strategic alliances to capitalize on unique market dynamics.

Key Company Insights and Competitive Landscape

An analysis of corporate capabilities and strategic priorities among leading players highlights a competitive landscape defined by specialization, collaboration, and continuous innovation. Advanced Porcine Research Inc. and PKC BioDynamics Inc. have invested heavily in experimental protocol optimization for nephrotoxicity studies, driving reproducibility across preclinical safety assessments. AgroBiotech Porcine Ltd. and Precision Porcine Technologies LLC are pioneering bioreactor innovation programs to achieve higher cell densities for antibody production and biological compound synthesis. BioCell Dynamics Inc. and Porcine Biomedical Solutions Ltd. have established integrated platforms that bridge disease modeling workflows with automation integration, boosting throughput for drug discovery pipelines. Meanwhile, Biologics for Porcine Inc. and RenalPorcine Research Corp. are scaling co-culture systems to support xenotransplantation research and regenerative applications. Companies such as CellMatrix Porcine Industries Inc. and Porcine Cell Science Corp. lead in three-dimensional culture models, while others like Innovative Porcine Solutions Inc. and Porcine Life Sciences Inc. focus on safety profiling and dose optimization methodologies. This mosaic of expertise signals a trend toward modular partnerships, joint ventures, and cross-sector alliances to deliver end-to-end solutions.

Actionable Recommendations for Industry Leaders

To capitalize on the evolving landscape, industry leaders should prioritize the following actions: 1. Strengthen vertical integration by establishing in-house capabilities for high-value inputs such as porcine-derived media supplements and custom bioreactor consumables, thereby reducing tariff exposure and ensuring supply continuity. 2. Invest in advanced analytics and digital twin technologies to optimize experimental protocol design and accelerate process qualification across disease modeling and nephrotoxicity assays. 3. Forge strategic collaborations between pharmaceutical production teams and veterinary research units to cross-pollinate methodologies in antibody production, vaccination development, and xenotransplantation research. 4. Localize manufacturing footprint by partnering with regional contract research organizations in the Americas, EMEA, and Asia-Pacific to leverage cost arbitrage, regulatory alignment, and proximity to key customer bases. 5. Expand service portfolios to include turnkey automation integration and three-dimensional co-culture system offerings, addressing the rising demand for functional models in drug discovery, safety profiling, and regenerative medicine. By executing these recommendations, companies can enhance operational resilience, accelerate innovation cycles, and solidify market leadership.

Conclusion: Navigating Complexity to Achieve Sustainable Growth

The porcine kidney cell market stands at a pivotal juncture where scientific ingenuity and strategic foresight intersect. Technological advancements in cell culture and bioprocessing are unlocking new application domains, from refined disease models to scalable regenerative therapies. Simultaneously, regulatory evolutions and trade policy shifts demand agile supply-chain architectures and robust risk-management frameworks. By harnessing segmentation intelligence, regional insights, and competitive benchmarking, stakeholders can navigate complexities with confidence. The integration of automation, digital analytics, and advanced culture systems will differentiate leading organizations, while targeted collaborations will drive both cost efficiencies and scientific breakthroughs. As the sector continues to mature, those who proactively align investments with emerging demands-prioritizing both quality standards and market responsiveness-will shape the future of porcine kidney cell utilization across research, clinical, and industrial settings.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Biomedical Research
    • Disease Modeling
      • Experimental Protocol Optimization
    • Drug Discovery And Development
    • Nephrotoxicity Studies
  • Pharmaceutical Production
    • Antibody Production
    • Biological Compound Synthesis
    • Vaccination Development
  • Veterinary Medicine
    • Animal Health Diagnostics
    • Regenerative Research
    • Xenotransplantation Research
  • Toxicology Testing
    • Chemical Exposure Analysis
    • Risk Assessment Procedures
      • Dose Optimization Methods
    • Safety Profiling
  • Technological Advancements
    • Automation Integration
    • Bioreactor Innovation
    • Cell Culture Techniques
      • 3D Culture Models
      • Co Culture Systems
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • Advanced Porcine Research Inc.
  • AgroBiotech Porcine Ltd.
  • BioCell Dynamics Inc.
  • Biologics for Porcine Inc.
  • Biotech Porcine Innovations Ltd.
  • CellMatrix Porcine Industries Inc.
  • Cellular Biologics of Porcine Inc.
  • CellWorks Porcine LLC
  • Elite Porcine BioProducts Inc.
  • Innovative Porcine Solutions Inc.
  • Integrative Porcine Solutions LLC
  • KidneyCell Technologies LLC
  • NextGen Porcine BioEngineering Inc.
  • PKC BioDynamics Inc.
  • Porcine Biomedical Solutions Ltd.
  • Porcine BioSolutions Inc.
  • Porcine Cell Analytics Ltd.
  • Porcine Cell Care Corporation
  • Porcine Cell Manufacturing Ltd.
  • Porcine Cell Science Corp.
  • Porcine Cell Systems Corporation
  • Porcine Cellular Research Group LLC
  • Porcine Genomics Research Group Ltd.
  • Porcine Life Sciences Inc.
  • Porcine Organics Research Inc.
  • Porcine Tissue Engineering Corp.
  • Porcine Vitality Research Inc.
  • PorkTech Biosciences LLC
  • Precision Porcine Technologies LLC
  • RenalPorcine Research Corp.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Porcine Kidney Cells Market, by Biomedical Research
8.1. Introduction
8.2. Disease Modeling
8.2.1. Experimental Protocol Optimization
8.3. Drug Discovery And Development
8.4. Nephrotoxicity Studies
9. Porcine Kidney Cells Market, by Pharmaceutical Production
9.1. Introduction
9.2. Antibody Production
9.3. Biological Compound Synthesis
9.4. Vaccination Development
10. Porcine Kidney Cells Market, by Veterinary Medicine
10.1. Introduction
10.2. Animal Health Diagnostics
10.3. Regenerative Research
10.4. Xenotransplantation Research
11. Porcine Kidney Cells Market, by Toxicology Testing
11.1. Introduction
11.2. Chemical Exposure Analysis
11.3. Risk Assessment Procedures
11.3.1. Dose Optimization Methods
11.4. Safety Profiling
12. Porcine Kidney Cells Market, by Technological Advancements
12.1. Introduction
12.2. Automation Integration
12.3. Bioreactor Innovation
12.4. Cell Culture Techniques
12.4.1. 3D Culture Models
12.4.2. Co Culture Systems
13. Americas Porcine Kidney Cells Market
13.1. Introduction
13.2. Argentina
13.3. Brazil
13.4. Canada
13.5. Mexico
13.6. United States
14. Asia-Pacific Porcine Kidney Cells Market
14.1. Introduction
14.2. Australia
14.3. China
14.4. India
14.5. Indonesia
14.6. Japan
14.7. Malaysia
14.8. Philippines
14.9. Singapore
14.10. South Korea
14.11. Taiwan
14.12. Thailand
14.13. Vietnam
15. Europe, Middle East & Africa Porcine Kidney Cells Market
15.1. Introduction
15.2. Denmark
15.3. Egypt
15.4. Finland
15.5. France
15.6. Germany
15.7. Israel
15.8. Italy
15.9. Netherlands
15.10. Nigeria
15.11. Norway
15.12. Poland
15.13. Qatar
15.14. Russia
15.15. Saudi Arabia
15.16. South Africa
15.17. Spain
15.18. Sweden
15.19. Switzerland
15.20. Turkey
15.21. United Arab Emirates
15.22. United Kingdom
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Advanced Porcine Research Inc.
16.3.2. AgroBiotech Porcine Ltd.
16.3.3. BioCell Dynamics Inc.
16.3.4. Biologics for Porcine Inc.
16.3.5. Biotech Porcine Innovations Ltd.
16.3.6. CellMatrix Porcine Industries Inc.
16.3.7. Cellular Biologics of Porcine Inc.
16.3.8. CellWorks Porcine LLC
16.3.9. Elite Porcine BioProducts Inc.
16.3.10. Innovative Porcine Solutions Inc.
16.3.11. Integrative Porcine Solutions LLC
16.3.12. KidneyCell Technologies LLC
16.3.13. NextGen Porcine BioEngineering Inc.
16.3.14. PKC BioDynamics Inc.
16.3.15. Porcine Biomedical Solutions Ltd.
16.3.16. Porcine BioSolutions Inc.
16.3.17. Porcine Cell Analytics Ltd.
16.3.18. Porcine Cell Care Corporation
16.3.19. Porcine Cell Manufacturing Ltd.
16.3.20. Porcine Cell Science Corp.
16.3.21. Porcine Cell Systems Corporation
16.3.22. Porcine Cellular Research Group LLC
16.3.23. Porcine Genomics Research Group Ltd.
16.3.24. Porcine Life Sciences Inc.
16.3.25. Porcine Organics Research Inc.
16.3.26. Porcine Tissue Engineering Corp.
16.3.27. Porcine Vitality Research Inc.
16.3.28. PorkTech Biosciences LLC
16.3.29. Precision Porcine Technologies LLC
16.3.30. RenalPorcine Research Corp.
17. Research AI18. Research Statistics19. Research Contacts20. Research Articles21. Appendix
List of Figures
FIGURE 1. PORCINE KIDNEY CELLS MARKET MULTI-CURRENCY
FIGURE 2. PORCINE KIDNEY CELLS MARKET MULTI-LANGUAGE
FIGURE 3. PORCINE KIDNEY CELLS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL PORCINE KIDNEY CELLS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL PORCINE KIDNEY CELLS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL PORCINE KIDNEY CELLS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL PORCINE KIDNEY CELLS MARKET SIZE, BY BIOMEDICAL RESEARCH, 2024 VS 2030 (%)
FIGURE 8. GLOBAL PORCINE KIDNEY CELLS MARKET SIZE, BY BIOMEDICAL RESEARCH, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL PORCINE KIDNEY CELLS MARKET SIZE, BY PHARMACEUTICAL PRODUCTION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL PORCINE KIDNEY CELLS MARKET SIZE, BY PHARMACEUTICAL PRODUCTION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL PORCINE KIDNEY CELLS MARKET SIZE, BY VETERINARY MEDICINE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL PORCINE KIDNEY CELLS MARKET SIZE, BY VETERINARY MEDICINE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL PORCINE KIDNEY CELLS MARKET SIZE, BY TOXICOLOGY TESTING, 2024 VS 2030 (%)
FIGURE 14. GLOBAL PORCINE KIDNEY CELLS MARKET SIZE, BY TOXICOLOGY TESTING, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL PORCINE KIDNEY CELLS MARKET SIZE, BY TECHNOLOGICAL ADVANCEMENTS, 2024 VS 2030 (%)
FIGURE 16. GLOBAL PORCINE KIDNEY CELLS MARKET SIZE, BY TECHNOLOGICAL ADVANCEMENTS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS PORCINE KIDNEY CELLS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS PORCINE KIDNEY CELLS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES PORCINE KIDNEY CELLS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES PORCINE KIDNEY CELLS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC PORCINE KIDNEY CELLS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC PORCINE KIDNEY CELLS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA PORCINE KIDNEY CELLS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA PORCINE KIDNEY CELLS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. PORCINE KIDNEY CELLS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. PORCINE KIDNEY CELLS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. PORCINE KIDNEY CELLS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL PORCINE KIDNEY CELLS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL PORCINE KIDNEY CELLS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL PORCINE KIDNEY CELLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL PORCINE KIDNEY CELLS MARKET SIZE, BY BIOMEDICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL PORCINE KIDNEY CELLS MARKET SIZE, BY DISEASE MODELING, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL PORCINE KIDNEY CELLS MARKET SIZE, BY EXPERIMENTAL PROTOCOL OPTIMIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL PORCINE KIDNEY CELLS MARKET SIZE, BY DISEASE MODELING, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL PORCINE KIDNEY CELLS MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL PORCINE KIDNEY CELLS MARKET SIZE, BY NEPHROTOXICITY STUDIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL PORCINE KIDNEY CELLS MARKET SIZE, BY PHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL PORCINE KIDNEY CELLS MARKET SIZE, BY ANTIBODY PRODUCTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL PORCINE KIDNEY CELLS MARKET SIZE, BY BIOLOGICAL COMPOUND SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL PORCINE KIDNEY CELLS MARKET SIZE, BY VACCINATION DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL PORCINE KIDNEY CELLS MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL PORCINE KIDNEY CELLS MARKET SIZE, BY ANIMAL HEALTH DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL PORCINE KIDNEY CELLS MARKET SIZE, BY REGENERATIVE RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL PORCINE KIDNEY CELLS MARKET SIZE, BY XENOTRANSPLANTATION RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL PORCINE KIDNEY CELLS MARKET SIZE, BY TOXICOLOGY TESTING, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL PORCINE KIDNEY CELLS MARKET SIZE, BY CHEMICAL EXPOSURE ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL PORCINE KIDNEY CELLS MARKET SIZE, BY RISK ASSESSMENT PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL PORCINE KIDNEY CELLS MARKET SIZE, BY DOSE OPTIMIZATION METHODS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL PORCINE KIDNEY CELLS MARKET SIZE, BY RISK ASSESSMENT PROCEDURES, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL PORCINE KIDNEY CELLS MARKET SIZE, BY SAFETY PROFILING, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL PORCINE KIDNEY CELLS MARKET SIZE, BY TECHNOLOGICAL ADVANCEMENTS, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL PORCINE KIDNEY CELLS MARKET SIZE, BY AUTOMATION INTEGRATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL PORCINE KIDNEY CELLS MARKET SIZE, BY BIOREACTOR INNOVATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL PORCINE KIDNEY CELLS MARKET SIZE, BY CELL CULTURE TECHNIQUES, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL PORCINE KIDNEY CELLS MARKET SIZE, BY 3D CULTURE MODELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL PORCINE KIDNEY CELLS MARKET SIZE, BY CO CULTURE SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL PORCINE KIDNEY CELLS MARKET SIZE, BY CELL CULTURE TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS PORCINE KIDNEY CELLS MARKET SIZE, BY BIOMEDICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS PORCINE KIDNEY CELLS MARKET SIZE, BY DISEASE MODELING, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS PORCINE KIDNEY CELLS MARKET SIZE, BY PHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS PORCINE KIDNEY CELLS MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS PORCINE KIDNEY CELLS MARKET SIZE, BY TOXICOLOGY TESTING, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS PORCINE KIDNEY CELLS MARKET SIZE, BY RISK ASSESSMENT PROCEDURES, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS PORCINE KIDNEY CELLS MARKET SIZE, BY TECHNOLOGICAL ADVANCEMENTS, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS PORCINE KIDNEY CELLS MARKET SIZE, BY CELL CULTURE TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS PORCINE KIDNEY CELLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 42. ARGENTINA PORCINE KIDNEY CELLS MARKET SIZE, BY BIOMEDICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 43. ARGENTINA PORCINE KIDNEY CELLS MARKET SIZE, BY DISEASE MODELING, 2018-2030 (USD MILLION)
TABLE 44. ARGENTINA PORCINE KIDNEY CELLS MARKET SIZE, BY PHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 45. ARGENTINA PORCINE KIDNEY CELLS MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
TABLE 46. ARGENTINA PORCINE KIDNEY CELLS MARKET SIZE, BY TOXICOLOGY TESTING, 2018-2030 (USD MILLION)
TABLE 47. ARGENTINA PORCINE KIDNEY CELLS MARKET SIZE, BY RISK ASSESSMENT PROCEDURES, 2018-2030 (USD MILLION)
TABLE 48. ARGENTINA PORCINE KIDNEY CELLS MARKET SIZE, BY TECHNOLOGICAL ADVANCEMENTS, 2018-2030 (USD MILLION)
TABLE 49. ARGENTINA PORCINE KIDNEY CELLS MARKET SIZE, BY CELL CULTURE TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 50. BRAZIL PORCINE KIDNEY CELLS MARKET SIZE, BY BIOMEDICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 51. BRAZIL PORCINE KIDNEY CELLS MARKET SIZE, BY DISEASE MODELING, 2018-2030 (USD MILLION)
TABLE 52. BRAZIL PORCINE KIDNEY CELLS MARKET SIZE, BY PHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 53. BRAZIL PORCINE KIDNEY CELLS MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
TABLE 54. BRAZIL PORCINE KIDNEY CELLS MARKET SIZE, BY TOXICOLOGY TESTING, 2018-2030 (USD MILLION)
TABLE 55. BRAZIL PORCINE KIDNEY CELLS MARKET SIZE, BY RISK ASSESSMENT PROCEDURES, 2018-2030 (USD MILLION)
TABLE 56. BRAZIL PORCINE KIDNEY CELLS MARKET SIZE, BY TECHNOLOGICAL ADVANCEMENTS, 2018-2030 (USD MILLION)
TABLE 57. BRAZIL PORCINE KIDNEY CELLS MARKET SIZE, BY CELL CULTURE TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 58. CANADA PORCINE KIDNEY CELLS MARKET SIZE, BY BIOMEDICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 59. CANADA PORCINE KIDNEY CELLS MARKET SIZE, BY DISEASE MODELING, 2018-2030 (USD MILLION)
TABLE 60. CANADA PORCINE KIDNEY CELLS MARKET SIZE, BY PHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 61. CANADA PORCINE KIDNEY CELLS MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
TABLE 62. CANADA PORCINE KIDNEY CELLS MARKET SIZE, BY TOXICOLOGY TESTING, 2018-2030 (USD MILLION)
TABLE 63. CANADA PORCINE KIDNEY CELLS MARKET SIZE, BY RISK ASSESSMENT PROCEDURES, 2018-2030 (USD MILLION)
TABLE 64. CANADA PORCINE KIDNEY CELLS MARKET SIZE, BY TECHNOLOGICAL ADVANCEMENTS, 2018-2030 (USD MILLION)
TABLE 65. CANADA PORCINE KIDNEY CELLS MARKET SIZE, BY CELL CULTURE TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 66. MEXICO PORCINE KIDNEY CELLS MARKET SIZE, BY BIOMEDICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 67. MEXICO PORCINE KIDNEY CELLS MARKET SIZE, BY DISEASE MODELING, 2018-2030 (USD MILLION)
TABLE 68. MEXICO PORCINE KIDNEY CELLS MARKET SIZE, BY PHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 69. MEXICO PORCINE KIDNEY CELLS MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
TABLE 70. MEXICO PORCINE KIDNEY CELLS MARKET SIZE, BY TOXICOLOGY TESTING, 2018-2030 (USD MILLION)
TABLE 71. MEXICO PORCINE KIDNEY CELLS MARKET SIZE, BY RISK ASSESSMENT PROCEDURES, 2018-2030 (USD MILLION)
TABLE 72. MEXICO PORCINE KIDNEY CELLS MARKET SIZE, BY TECHNOLOGICAL ADVANCEMENTS, 2018-2030 (USD MILLION)
TABLE 73. MEXICO PORCINE KIDNEY CELLS MARKET SIZE, BY CELL CULTURE TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES PORCINE KIDNEY CELLS MARKET SIZE, BY BIOMEDICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES PORCINE KIDNEY CELLS MARKET SIZE, BY DISEASE MODELING, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES PORCINE KIDNEY CELLS MARKET SIZE, BY PHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES PORCINE KIDNEY CELLS MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES PORCINE KIDNEY CELLS MARKET SIZE, BY TOXICOLOGY TESTING, 2018-2030 (USD MILLION)
TABLE 79. UNITED STATES PORCINE KIDNEY CELLS MARKET SIZE, BY RISK ASSESSMENT PROCEDURES, 2018-2030 (USD MILLION)
TABLE 80. UNITED STATES PORCINE KIDNEY CELLS MARKET SIZE, BY TECHNOLOGICAL ADVANCEMENTS, 2018-2030 (USD MILLION)
TABLE 81. UNITED STATES PORCINE KIDNEY CELLS MARKET SIZE, BY CELL CULTURE TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES PORCINE KIDNEY CELLS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 83. ASIA-PACIFIC PORCINE KIDNEY CELLS MARKET SIZE, BY BIOMEDICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 84. ASIA-PACIFIC PORCINE KIDNEY CELLS MARKET SIZE, BY DISEASE MODELING, 2018-2030 (USD MILLION)
TABLE 85. ASIA-PACIFIC PORCINE KIDNEY CELLS MARKET SIZE, BY PHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 86. ASIA-PACIFIC PORCINE KIDNEY CELLS MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
TABLE 87. ASIA-PACIFIC PORCINE KIDNEY CELLS MARKET SIZE, BY TOXICOLOGY TESTING, 2018-2030 (USD MILLION)
TABLE 88. ASIA-PACIFIC PORCINE KIDNEY CELLS MARKET SIZE, BY RISK ASSESSMENT PROCEDURES, 2018-2030 (USD MILLION)
TABLE 89. ASIA-PACIFIC PORCINE KIDNEY CELLS MARKET SIZE, BY TECHNOLOGICAL ADVANCEMENTS, 2018-2030 (USD MILLION)
TABLE 90. ASIA-PACIFIC PORCINE KIDNEY CELLS MARKET SIZE, BY CELL CULTURE TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 91. ASIA-PACIFIC PORCINE KIDNEY CELLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 92. AUSTRALIA PORCINE KIDNEY CELLS MARKET SIZE, BY BIOMEDICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 93. AUSTRALIA PORCINE KIDNEY CELLS MARKET SIZE, BY DISEASE MODELING, 2018-2030 (USD MILLION)
TABLE 94. AUSTRALIA PORCINE KIDNEY CELLS MARKET SIZE, BY PHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 95. AUSTRALIA PORCINE KIDNEY CELLS MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
TABLE 96. AUSTRALIA PORCINE KIDNEY CELLS MARKET SIZE, BY TOXICOLOGY TESTING, 2018-2030 (USD MILLION)
TABLE 97. AUSTRALIA PORCINE KIDNEY CELLS MARKET SIZE, BY RISK ASSESSMENT PROCEDURES, 2018-2030 (USD MILLION)
TABLE 98. AUSTRALIA PORCINE KIDNEY CELLS MARKET SIZE, BY TECHNOLOGICAL ADVANCEMENTS, 2018-2030 (USD MILLION)
TABLE 99. AUSTRALIA PORCINE KIDNEY CELLS MARKET SIZE, BY CELL CULTURE TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 100. CHINA PORCINE KIDNEY CELLS MARKET SIZE, BY BIOMEDICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 101. CHINA PORCINE KIDNEY CELLS MARKET SIZE, BY DISEASE MODELING, 2018-2030 (USD MILLION)
TABLE 102. CHINA PORCINE KIDNEY CELLS MARKET SIZE, BY PHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 103. CHINA PORCINE KIDNEY CELLS MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
TABLE 104. CHINA PORCINE KIDNEY CELLS MARKET SIZE, BY TOXICOLOGY TESTING, 2018-2030 (USD MILLION)
TABLE 105. CHINA PORCINE KIDNEY CELLS MARKET SIZE, BY RISK ASSESSMENT PROCEDURES, 2018-2030 (USD MILLION)
TABLE 106. CHINA PORCINE KIDNEY CELLS MARKET SIZE, BY TECHNOLOGICAL ADVANCEMENTS, 2018-2030 (USD MILLION)
TABLE 107. CHINA PORCINE KIDNEY CELLS MARKET SIZE, BY CELL CULTURE TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 108. INDIA PORCINE KIDNEY CELLS MARKET SIZE, BY BIOMEDICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 109. INDIA PORCINE KIDNEY CELLS MARKET SIZE, BY DISEASE MODELING, 2018-2030 (USD MILLION)
TABLE 110. INDIA PORCINE KIDNEY CELLS MARKET SIZE, BY PHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 111. INDIA PORCINE KIDNEY CELLS MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
TABLE 112. INDIA PORCINE KIDNEY CELLS MARKET SIZE, BY TOXICOLOGY TESTING, 2018-2030 (USD MILLION)
TABLE 113. INDIA PORCINE KIDNEY CELLS MARKET SIZE, BY RISK ASSESSMENT PROCEDURES, 2018-2030 (USD MILLION)
TABLE 114. INDIA PORCINE KIDNEY CELLS MARKET SIZE, BY TECHNOLOGICAL ADVANCEMENTS, 2018-2030 (USD MILLION)
TABLE 115. INDIA PORCINE KIDNEY CELLS MARKET SIZE, BY CELL CULTURE TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 116. INDONESIA PORCINE KIDNEY CELLS MARKET SIZE, BY BIOMEDICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 117. INDONESIA PORCINE KIDNEY CELLS MARKET SIZE, BY DISEASE MODELING, 2018-2030 (USD MILLION)
TABLE 118. INDONESIA PORCINE KIDNEY CELLS MARKET SIZE, BY PHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 119. INDONESIA PORCINE KIDNEY CELLS MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
TABLE 120. INDONESIA PORCINE KIDNEY CELLS MARKET SIZE, BY TOXICOLOGY TESTING, 2018-2030 (USD MILLION)
TABLE 121. INDONESIA PORCINE KIDNEY CELLS MARKET SIZE, BY RISK ASSESSMENT PROCEDURES, 2018-2030 (USD MILLION)
TABLE 122. INDONESIA PORCINE KIDNEY CELLS MARKET SIZE, BY TECHNOLOGICAL ADVANCEMENTS, 2018-2030 (USD MILLION)
TABLE 123. INDONESIA PORCINE KIDNEY CELLS MARKET SIZE, BY CELL CULTURE TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 124. JAPAN PORCINE KIDNEY CELLS MARKET SIZE, BY BIOMEDICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 125. JAPAN PORCINE KIDNEY CELLS MARKET SIZE, BY DISEASE MODELING, 2018-2030 (USD MILLION)
TABLE 126. JAPAN PORCINE KIDNEY CELLS MARKET SIZE, BY PHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 127. JAPAN PORCINE KIDNEY CELLS MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
TABLE 128. JAPAN PORCINE KIDNEY CELLS MARKET SIZE, BY TOXICOLOGY TESTING, 2018-2030 (USD MILLION)
TABLE 129. JAPAN PORCINE KIDNEY CELLS MARKET SIZE, BY RISK ASSESSMENT PROCEDURES, 2018-2030 (USD MILLION)
TABLE 130. JAPAN PORCINE KIDNEY CELLS MARKET SIZE, BY TECHNOLOGICAL ADVANCEMENTS, 2018-2030 (USD MILLION)
TABLE 131. JAPAN PORCINE KIDNEY CELLS MARKET SIZE, BY CELL CULTURE TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 132. MALAYSIA PORCINE KIDNEY CELLS MARKET SIZE, BY BIOMEDICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 133. MALAYSIA PORCINE KIDNEY CELLS MARKET SIZE, BY DISEASE MODELING, 2018-2030 (USD MILLION)
TABLE 134. MALAYSIA PORCINE KIDNEY CELLS MARKET SIZE, BY PHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 135. MALAYSIA PORCINE KIDNEY CELLS MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
TABLE 136. MALAYSIA PORCINE KIDNEY CELLS MARKET SIZE, BY TOXICOLOGY TESTING, 2018-2030 (USD MILLION)
TABLE 137. MALAYSIA PORCINE KIDNEY CELLS MARKET SIZE, BY RISK ASSESSMENT PROCEDURES, 2018-2030 (USD MILLION)
TABLE 138. MALAYSIA PORCINE KIDNEY CELLS MARKET SIZE, BY TECHNOLOGICAL ADVANCEMENTS, 2018-2030 (USD MILLION)
TABLE 139. MALAYSIA PORCINE KIDNEY CELLS MARKET SIZE, BY CELL CULTURE TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 140. PHILIPPINES PORCINE KIDNEY CELLS MARKET SIZE, BY BIOMEDICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 141. PHILIPPINES PORCINE KIDNEY CELLS MARKET SIZE, BY DISEASE MODELING, 2018-2030 (USD MILLION)
TABLE 142. PHILIPPINES PORCINE KIDNEY CELLS MARKET SIZE, BY PHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 143. PHILIPPINES PORCINE KIDNEY CELLS MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
TABLE 144. PHILIPPINES PORCINE KIDNEY CELLS MARKET SIZE, BY TOXICOLOGY TESTING, 2018-2030 (USD MILLION)
TABLE 145. PHILIPPINES PORCINE KIDNEY CELLS MARKET SIZE, BY RISK ASSESSMENT PROCEDURES, 2018-2030 (USD MILLION)
TABLE 146. PHILIPPINES PORCINE KIDNEY CELLS MARKET SIZE, BY TECHNOLOGICAL ADVANCEMENTS, 2018-2030 (USD MILLION)
TABLE 147. PHILIPPINES PORCINE KIDNEY CELLS MARKET SIZE, BY CELL CULTURE TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 148. SINGAPORE PORCINE KIDNEY CELLS MARKET SIZE, BY BIOMEDICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 149. SINGAPORE PORCINE KIDNEY CELLS MARKET SIZE, BY DISEASE MODELING, 2018-2030 (USD MILLION)
TABLE 150. SINGAPORE PORCINE KIDNEY CELLS MARKET SIZE, BY PHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 151. SINGAPORE PORCINE KIDNEY CELLS MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
TABLE 152. SINGAPORE PORCINE KIDNEY CELLS MARKET SIZE, BY TOXICOLOGY TESTING, 2018-2030 (USD MILLION)
TABLE 153. SINGAPORE PORCINE KIDNEY CELLS MARKET SIZE, BY RISK ASSESSMENT PROCEDURES, 2018-2030 (USD MILLION)
TABLE 154. SINGAPORE PORCINE KIDNEY CELLS MARKET SIZE, BY TECHNOLOGICAL ADVANCEMENTS, 2018-2030 (USD MILLION)
TABLE 155. SINGAPORE PORCINE KIDNEY CELLS MARKET SIZE, BY CELL CULTURE TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 156. SOUTH KOREA PORCINE KIDNEY CELLS MARKET SIZE, BY BIOMEDICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 157. SOUTH KOREA PORCINE KIDNEY CELLS MARKET SIZE, BY DISEASE MODELING, 2018-2030 (USD MILLION)
TABLE 158. SOUTH KOREA PORCINE KIDNEY CELLS MARKET SIZE, BY PHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 159. SOUTH KOREA PORCINE KIDNEY CELLS MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
TABLE 160. SOUTH KOREA PORCINE KIDNEY CELLS MARKET SIZE, BY TOXICOLOGY TESTING, 2018-2030 (USD MILLION)
TABLE 161. SOUTH KOREA PORCINE KIDNEY CELLS MARKET SIZE, BY RISK ASSESSMENT PROCEDURES, 2018-2030 (USD MILLION)
TABLE 162. SOUTH KOREA PORCINE KIDNEY CELLS MARKET SIZE, BY TECHNOLOGICAL ADVANCEMENTS, 2018-2030 (USD MILLION)
TABLE 163. SOUTH KOREA PORCINE KIDNEY CELLS MARKET SIZE, BY CELL CULTURE TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 164. TAIWAN PORCINE KIDNEY CELLS MARKET SIZE, BY BIOMEDICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 165. TAIWAN PORCINE KIDNEY CELLS MARKET SIZE, BY DISEASE MODELING, 2018-2030 (USD MILLION)
TABLE 166. TAIWAN PORCINE KIDNEY CELLS MARKET SIZE, BY PHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 167. TAIWAN PORCINE KIDNEY CELLS MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
TABLE 168. TAIWAN PORCINE KIDNEY CELLS MARKET SIZE, BY TOXICOLOGY TESTING, 2018-2030 (USD MILLION)
TABLE 169. TAIWAN PORCINE KIDNEY CELLS MARKET SIZE, BY RISK ASSESSMENT PROCEDURES, 2018-2030 (USD MILLION)
TABLE 170. TAIWAN PORCINE KIDNEY CELLS MARKET SIZE, BY TECHNOLOGICAL ADVANCEMENTS, 2018-2030 (USD MILLION)
TABLE 171. TAIWAN PORCINE KIDNEY CELLS MARKET SIZE, BY CELL CULTURE TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 172. THAILAND PORCINE KIDNEY CELLS MARKET SIZE, BY BIOMEDICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 173. THAILAND PORCINE KIDNEY CELLS MARKET SIZE, BY DISEASE MODELING, 2018-2030 (USD MILLION)
TABLE 174. THAILAND PORCINE KIDNEY CELLS MARKET SIZE, BY PHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 175. THAILAND PORCINE KIDNEY CELLS MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
TABLE 176. THAILAND PORCINE KIDNEY CELLS MARKET SIZE, BY TOXICOLOGY TESTING, 2018-2030 (USD MILLION)
TABLE 177. THAILAND PORCINE KIDNEY CELLS MARKET SIZE, BY RISK ASSESSMENT PROCEDURES, 2018-2030 (USD MILLION)
TABLE 178. THAILAND PORCINE KIDNEY CELLS MARKET SIZE, BY TECHNOLOGICAL ADVANCEMENTS, 2018-2030 (USD MILLION)
TABLE 179. THAILAND PORCINE KIDNEY CELLS MARKET SIZE, BY CELL CULTURE TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 180. VIETNAM PORCINE KIDNEY CELLS MARKET SIZE, BY BIOMEDICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 181. VIETNAM PORCINE KIDNEY CELLS MARKET SIZE, BY DISEASE MODELING, 2018-2030 (USD MILLION)
TABLE 182. VIETNAM PORCINE KIDNEY CELLS MARKET SIZE, BY PHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 183. VIETNAM PORCINE KIDNEY CELLS MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
TABLE 184. VIETNAM PORCINE KIDNEY CELLS MARKET SIZE, BY TOXICOLOGY TESTING, 2018-2030 (USD MILLION)
TABLE 185. VIETNAM PORCINE KIDNEY CELLS MARKET SIZE, BY RISK ASSESSMENT PROCEDURES, 2018-2030 (USD MILLION)
TABLE 186. VIETNAM PORCINE KIDNEY CELLS MARKET SIZE, BY TECHNOLOGICAL ADVANCEMENTS, 2018-2030 (USD MILLION)
TABLE 187. VIETNAM PORCINE KIDNEY CELLS MARKET SIZE, BY CELL CULTURE TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA PORCINE KIDNEY CELLS MARKET SIZE, BY BIOMEDICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA PORCINE KIDNEY CELLS MARKET SIZE, BY DISEASE MODELING, 2018-2030 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA PORCINE KIDNEY CELLS MARKET SIZE, BY PHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA PORCINE KIDNEY CELLS MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA PORCINE KIDNEY CELLS MARKET SIZE, BY TOXICOLOGY TESTING, 2018-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA PORCINE KIDNEY CELLS MARKET SIZE, BY RISK ASSESSMENT PROCEDURES, 2018-2030 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA PORCINE KIDNEY CELLS MARKET SIZE, BY TECHNOLOGICAL ADVANCEMENTS, 2018-2030 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA PORCINE KIDNEY CELLS MARKET SIZE, BY CELL CULTURE TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA PORCINE KIDNEY CELLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 197. DENMARK PORCINE KIDNEY CELLS MARKET SIZE, BY BIOMEDICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 198. DENMARK PORCINE KIDNEY CELLS MARKET SIZE, BY DISEASE MODELING, 2018-2030 (USD MILLION)
TABLE 199. DENMARK PORCINE KIDNEY CELLS MARKET SIZE, BY PHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 200. DENMARK PORCINE KIDNEY CELLS MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
TABLE 201. DENMARK PORCINE KIDNEY CELLS MARKET SIZE, BY TOXICOLOGY TESTING, 2018-2030 (USD MILLION)
TABLE 202. DENMARK PORCINE KIDNEY CELLS MARKET SIZE, BY RISK ASSESSMENT PROCEDURES, 2018-2030 (USD MILLION)
TABLE 203. DENMARK PORCINE KIDNEY CELLS MARKET SIZE, BY TECHNOLOGICAL ADVANCEMENTS, 2018-2030 (USD MILLION)
TABLE 204. DENMARK PORCINE KIDNEY CELLS MARKET SIZE, BY CELL CULTURE TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 205. EGYPT PORCINE KIDNEY CELLS MARKET SIZE, BY BIOMEDICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 206. EGYPT PORCINE KIDNEY CELLS MARKET SIZE, BY DISEASE MODELING, 2018-2030 (USD MILLION)
TABLE 207. EGYPT PORCINE KIDNEY CELLS MARKET SIZE, BY PHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 208. EGYPT PORCINE KIDNEY CELLS MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
TABLE 209. EGYPT PORCINE KIDNEY CELLS MARKET SIZE, BY TOXICOLOGY TESTING, 2018-2030 (USD MILLION)
TABLE 210. EGYPT PORCINE KIDNEY CELLS MARKET SIZE, BY RISK ASSESSMENT PROCEDURES, 2018-2030 (USD MILLION)
TABLE 211. EGYPT PORCINE KIDNEY CELLS MARKET SIZE, BY TECHNOLOGICAL ADVANCEMENTS, 2018-2030 (USD MILLION)
TABLE 212. EGYPT PORCINE KIDNEY CELLS MARKET SIZE, BY CELL CULTURE TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 213. FINLAND PORCINE KIDNEY CELLS MARKET SIZE, BY BIOMEDICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 214. FINLAND PORCINE KIDNEY CELLS MARKET SIZE, BY DISEASE MODELING, 2018-2030 (USD MILLION)
TABLE 215. FINLAND PORCINE KIDNEY CELLS MARKET SIZE, BY PHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 216. FINLAND PORCINE KIDNEY CELLS MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
TABLE 217. FINLAND PORCINE KIDNEY CELLS MARKET SIZE, BY TOXICOLOGY TESTING, 2018-2030 (USD MILLION)
TABLE 218. FINLAND PORCINE KIDNEY CELLS MARKET SIZE, BY RISK ASSESSMENT PROCEDURES, 2018-2030 (USD MILLION)
TABLE 219. FINLAND PORCINE KIDNEY CELLS MARKET SIZE, BY TECHNOLOGICAL ADVANCEMENTS, 2018-2030 (USD MILLION)
TABLE 220. FINLAND PORCINE KIDNEY CELLS MARKET SIZE, BY CELL CULTURE TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 221. FRANCE PORCINE KIDNEY CELLS MARKET SIZE, BY BIOMEDICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 222. FRANCE PORCINE KIDNEY CELLS MARKET SIZE, BY DISEASE MODELING, 2018-2030 (USD MILLION)
TABLE 223. FRANCE PORCINE KIDNEY CELLS MARKET SIZE, BY PHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 224. FRANCE PORCINE KIDNEY CELLS MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
TABLE 225. FRANCE PORCINE KIDNEY CELLS MARKET SIZE, BY TOXICOLOGY TESTING, 2018-2030 (USD MILLION)
TABLE 226. FRANCE PORCINE KIDNEY CELLS MARKET SIZE, BY RISK ASSESSMENT PROCEDURES, 2018-2030 (USD MILLION)
TABLE 227. FRANCE PORCINE KIDNEY CELLS MARKET SIZE, BY TECHNOLOGICAL ADVANCEMENTS, 2018-2030 (USD MILLION)
TABLE 228. FRANCE PORCINE KIDNEY CELLS MARKET SIZE, BY CELL CULTURE TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 229. GERMANY PORCINE KIDNEY CELLS MARKET SIZE, BY BIOMEDICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 230. GERMANY PORCINE KIDNEY CELLS MARKET SIZE, BY DISEASE MODELING, 2018-2030 (USD MILLION)
TABLE 231. GERMANY PORCINE KIDNEY CELLS MARKET SIZE, BY PHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 232. GERMANY PORCINE KIDNEY CELLS MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
TABLE 233. GERMANY PORCINE KIDNEY CELLS MARKET SIZE, BY TOXICOLOGY TESTING, 2018-2030 (USD MILLION)
TABLE 234. GERMANY PORCINE KIDNEY CELLS MARKET SIZE, BY RISK ASSESSMENT PROCEDURES, 2018-2030 (USD MILLION)
TABLE 235. GERMANY PORCINE KIDNEY CELLS MARKET SIZE, BY TECHNOLOGICAL ADVANCEMENTS, 2018-2030 (USD MILLION)
TABLE 236. GERMANY PORCINE KIDNEY CELLS MARKET SIZE, BY CELL CULTURE TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 237. ISRAEL PORCINE KIDNEY CELLS MARKET SIZE, BY BIOMEDICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 238. ISRAEL PORCINE KIDNEY CELLS MARKET SIZE, BY DISEASE MODELING, 2018-2030 (USD MILLION)
TABLE 239. ISRAEL PORCINE KIDNEY CELLS MARKET SIZE, BY PHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 240. ISRAEL PORCINE KIDNEY CELLS MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
TABLE 241. ISRAEL PORCINE KIDNEY CELLS MARKET SIZE, BY TOXICOLOGY TESTING, 2018-2030 (USD MILLION)
TABLE 242. ISRAEL PORCINE KIDNEY CELLS MARKET SIZE, BY RISK ASSESSMENT PROCEDURES, 2018-2030 (USD MILLION)
TABLE 243. ISRAEL PORCINE KIDNEY CELLS MARKET SIZE, BY TECHNOLOGICAL ADVANCEMENTS, 2018-2030 (USD MILLION)
TABLE 244. ISRAEL PORCINE KIDNEY CELLS MARKET SIZE, BY CELL CULTURE TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 245. ITALY PORCINE KIDNEY CELLS MARKET SIZE, BY BIOMEDICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 246. ITALY PORCINE KIDNEY CELLS MARKET SIZE, BY DISEASE MODELING, 2018-2030 (USD MILLION)
TABLE 247. ITALY PORCINE KIDNEY CELLS MARKET SIZE, BY PHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 248. ITALY PORCINE KIDNEY CELLS MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
TABLE 249. ITALY PORCINE KIDNEY CELLS MARKET SIZE, BY TOXICOLOGY TESTING, 2018-2030 (USD MILLION)
TABLE 250. ITALY PORCINE KIDNEY CELLS MARKET SIZE, BY RISK ASSESSMENT PROCEDURES, 2018-2030 (USD MILLION)
TABLE 251. ITALY PORCINE KIDNEY CELLS MARKET SIZE, BY TECHNOLOGICAL ADVANCEMENTS, 2018-2030 (USD MILLION)
TABLE 252. ITALY PORCINE KIDNEY CELLS MARKET SIZE, BY CELL CULTURE TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 253. NETHERLANDS PORCINE KIDNEY CELLS MARKET SIZE, BY BIOMEDICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 254. NETHERLANDS PORCINE KIDNEY CELLS MARKET SIZE, BY DISEASE MODELING, 2018-2030 (USD MILLION)
TABLE 255. NETHERLANDS PORCINE KIDNEY CELLS MARKET SIZE, BY PHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 256. NETHERLANDS PORCINE KIDNEY CELLS MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
TABLE 257. NETHERLANDS PORCINE KIDNEY CELLS MARKET SIZE, BY TOXICOLOGY TESTING, 2018-2030 (USD MILLION)
TABLE 258. NETHERLANDS PORCINE KIDNEY CELLS MARKET SIZE, BY RISK ASSESSMENT PROCEDURES, 2018-2030 (USD MILLION)
TABLE 259. NETHERLANDS PORCINE KIDNEY CELLS MARKET SIZE, BY TECHNOLOGICAL ADVANCEMENTS, 2018-2030 (USD MILLION)
TABLE 260. NETHERLANDS PORCINE KIDNEY CELLS MARKET SIZE, BY CELL CULTURE TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 261. NIGERIA PORCINE KIDNEY CELLS MARKET SIZE, BY BIOMEDICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 262. NIGERIA PORCINE KIDNEY CELLS MARKET SIZE, BY DISEASE MODELING, 2018-2030 (USD MILLION)
TABLE 263. NIGERIA PORCINE KIDNEY CELLS MARKET SIZE, BY PHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 264. NIGERIA PORCINE KIDNEY CELLS MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
TABLE 265. NIGERIA PORCINE KIDNEY CELLS MARKET SIZE, BY TOXICOLOGY TESTING, 2018-2030 (USD MILLION)
TABLE 266. NIGERIA PORCINE KIDNEY CELLS MARKET SIZE, BY RISK ASSESSMENT PROCEDURES, 2018-2030 (USD MILLION)
TABLE 267. NIGERIA PORCINE KIDNEY CELLS MARKET SIZE, BY TECHNOLOGICAL ADVANCEMENTS, 2018-2030 (USD MILLION)
TABLE 268. NIGERIA PORCINE KIDNEY CELLS MARKET SIZE, BY CELL CULTURE TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 269. NORWAY PORCINE KIDNEY CELLS MARKET SIZE, BY BIOMEDICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 270. NORWAY PORCINE KIDNEY CELLS MARKET SIZE, BY DISEASE MODELING, 2018-2030 (USD MILLION)
TABLE 271. NORWAY PORCINE KIDNEY CELLS MARKET SIZE, BY PHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 272. NORWAY PORCINE KIDNEY CELLS MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
TABLE 273. NORWAY PORCINE KIDNEY CELLS MARKET SIZE, BY TOXICOLOGY TESTING, 2018-2030 (USD MILLION)
TABLE 274. NORWAY PORCINE KIDNEY CELLS MARKET SIZE, BY RISK ASSESSMENT PROCEDURES, 2018-2030 (USD MILLION)
TABLE 275. NORWAY PORCINE KIDNEY CELLS MARKET SIZE, BY TECHNOLOGICAL ADVANCEMENTS, 2018-2030 (USD MILLION)
TABLE 276. NORWAY PORCINE KIDNEY CELLS MARKET SIZE, BY CELL CULTURE TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 277. POLAND PORCINE KIDNEY CELLS MARKET SIZE, BY BIOMEDICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 278. POLAND PORCINE KIDNEY CELLS MARKET SIZE, BY DISEASE MODELING, 2018-2030 (USD MILLION)
TABLE 279. POLAND PORCINE KIDNEY CELLS MARKET SIZE, BY PHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 280. POLAND PORCINE KIDNEY CELLS MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
TABLE 281. POLAND PORCINE KIDNEY CELLS MARKET SIZE, BY TOXICOLOGY TESTING, 2018-2030 (USD MILLION)
TABLE 282. POLAND PORCINE KIDNEY CELLS MARKET SIZE, BY RISK ASSESSMENT PROCEDURES, 2018-2030 (USD MILLION)
TABLE 283. POLAND PORCINE KIDNEY CELLS MARKET SIZE, BY TECHNOLOGICAL ADVANCEMENTS, 2018-2030 (USD MILLION)
TABLE 284. POLAND PORCINE KIDNEY CELLS MARKET SIZE, BY CELL CULTURE TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 285. QATAR PORCINE KIDNEY CELLS MARKET SIZE, BY BIOMEDICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 286. QATAR PORCINE KIDNEY CELLS MARKET SIZE, BY DISEASE MODELING, 2018-2030 (USD MILLION)
TABLE 287. QATAR PORCINE KIDNEY CELLS MARKET SIZE, BY PHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 288. QATAR PORCINE KIDNEY CELLS MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
TABLE 289. QATAR PORCINE KIDNEY CELLS MARKET SIZE, BY TOXICOLOGY TESTING, 2018-2030 (USD MILLION)
TABLE 290. QATAR PORCINE KIDNEY CELLS MARKET SIZE, BY RISK ASSESSMENT PROCEDURES, 2018-2030 (USD MILLION)
TABLE 291. QATAR PORCINE KIDNEY CELLS MARKET SIZE, BY TECHNOLOGICAL ADVANCEMENTS, 2018-2030 (USD MILLION)
TABLE 292. QATAR PORCINE KIDNEY CELLS MARKET SIZE, BY CELL CULTURE TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 293. RUSSIA PORCINE KIDNEY CELLS MARKET SIZE, BY BIOMEDICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 294. RUSSIA PORCINE KIDNEY CELLS MARKET SIZE, BY DISEASE MODELING, 2018-2030 (USD MILLION)
TABLE 295. RUSSIA PORCINE KIDNEY CELLS MARKET SIZE, BY PHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 296. RUSSIA PORCINE KIDNEY CELLS MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
TABLE 297. RUSSIA PORCINE KIDNEY CELLS MARKET SIZE, BY TOXICOLOGY TESTING, 2018-2030 (USD MILLION)
TABLE 298. RUSSIA PORCINE KIDNEY CELLS MARKET SIZE, BY RISK ASSESSMENT PROCEDURES, 2018-2030 (USD MILLION)
TABLE 299. RUSSIA PORCINE KIDNEY CELLS MARKET SIZE, BY TECHNOLOGICAL ADVANCEMENTS, 2018-2030 (USD MILLION)
TABLE 300. RUSSIA PORCINE KIDNEY CELLS MARKET SIZE, BY CELL CULTURE TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 301. SAUDI ARABIA PORCINE KIDNEY CELLS MARKET SIZE, BY BIOMEDICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 302. SAUDI ARABIA PORCINE KIDNEY CELLS MARKET SIZE, BY DISEASE MODELING, 2018-2030 (USD MILLION)
TABLE 303. SAUDI ARABIA PORCINE KIDNEY CELLS MARKET SIZE, BY PHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 304. SAUDI ARABIA PORCINE KIDNEY CELLS MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
TABLE 305. SAUDI ARABIA PORCINE KIDNEY CELLS MARKET SIZE, BY TOXICOLOGY TESTING, 2018-2030 (USD MILLION)
TABLE 306. SAUDI ARABIA PORCINE KIDNEY CELLS MARKET SIZE, BY RISK ASSESSMENT PROCEDURES, 2018-2030 (USD MILLION)
TABLE 307. SAUDI ARABIA PORCINE KIDNEY CELLS MARKET SIZE, BY TECHNOLOGICAL ADVANCEMENTS, 2018-2030 (USD MILLION)
TABLE 308. SAUDI ARABIA PORCINE KIDNEY CELLS MARKET SIZE, BY CELL CULTURE TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 309. SOUTH AFRICA PORCINE KIDNEY CELLS MARKET SIZE, BY BIOMEDICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 310. SOUTH AFRICA PORCINE KIDNEY CELLS MARKET SIZE, BY DISEASE MODELING, 2018-2030 (USD MILLION)
TABLE 311. SOUTH AFRICA PORCINE KIDNEY CELLS MARKET SIZE, BY PHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 312. SOUTH AFRICA PORCINE KIDNEY CELLS MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
TABLE 313. SOUTH AFRICA PORCINE KIDNEY CELLS MARKET SIZE, BY TOXICOLOGY TESTING, 2018-2030 (USD MILLION)
TABLE 314. SOUTH AFRICA PORCINE KIDNEY CELLS MARKET SIZE, BY RISK ASSESSMENT PROCEDURES, 2018-2030 (USD MILLIO

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Porcine Kidney Cells Market report include:
  • Advanced Porcine Research Inc.
  • AgroBiotech Porcine Ltd.
  • BioCell Dynamics Inc.
  • Biologics for Porcine Inc.
  • Biotech Porcine Innovations Ltd.
  • CellMatrix Porcine Industries Inc.
  • Cellular Biologics of Porcine Inc.
  • CellWorks Porcine LLC
  • Elite Porcine BioProducts Inc.
  • Innovative Porcine Solutions Inc.
  • Integrative Porcine Solutions LLC
  • KidneyCell Technologies LLC
  • NextGen Porcine BioEngineering Inc.
  • PKC BioDynamics Inc.
  • Porcine Biomedical Solutions Ltd.
  • Porcine BioSolutions Inc.
  • Porcine Cell Analytics Ltd.
  • Porcine Cell Care Corporation
  • Porcine Cell Manufacturing Ltd.
  • Porcine Cell Science Corp.
  • Porcine Cell Systems Corporation
  • Porcine Cellular Research Group LLC
  • Porcine Genomics Research Group Ltd.
  • Porcine Life Sciences Inc.
  • Porcine Organics Research Inc.
  • Porcine Tissue Engineering Corp.
  • Porcine Vitality Research Inc.
  • PorkTech Biosciences LLC
  • Precision Porcine Technologies LLC
  • RenalPorcine Research Corp.

Related Topics

Related Reports

Porcine Vaccines Market by Vaccine Type (Inactivated, Live Attenuated, MRNA), Disease Indication (Classical Swine Fever, Erysipelas, Porcine Reproductive and Respiratory Syndrome), End User, Route Of Administration, Technology, Dosage Form - Global Forecast 2025-2030 - Product Image

Porcine Vaccines Market by Vaccine Type (Inactivated, Live Attenuated, MRNA), Disease Indication (Classical Swine Fever, Erysipelas, Porcine Reproductive and Respiratory Syndrome), End User, Route Of Administration, Technology, Dosage Form - Global Forecast 2025-2030

  • Report
  • 199 Pages
  • Global
From
Serum for Cell Culture Market by Product Type (Bovine Serum Albumin, Calf Serum, Fetal Bovine Serum), Application (Biopharmaceutical Manufacturing, Clinical Applications, Research and Development), End User, Source, Distribution Channel - Global Forecast 2025-2030 - Product Image

Serum for Cell Culture Market by Product Type (Bovine Serum Albumin, Calf Serum, Fetal Bovine Serum), Application (Biopharmaceutical Manufacturing, Clinical Applications, Research and Development), End User, Source, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 196 Pages
  • Global
From
Global Porcine Vaccine - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030) - Product Image

Global Porcine Vaccine - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

  • Report
  • 120 Pages
  • Global
From
Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market by Vaccine Type (Combination Vaccine, Monovalent Vaccine), Dosage Form (Liquid For Injection, Lyophilized Powder For Injection), Administration Route, End User, Animal Age Group, Sales Channel - Global Forecast 2025-2030 - Product Image

Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market by Vaccine Type (Combination Vaccine, Monovalent Vaccine), Dosage Form (Liquid For Injection, Lyophilized Powder For Injection), Administration Route, End User, Animal Age Group, Sales Channel - Global Forecast 2025-2030

  • Report
  • 187 Pages
  • Global
From
Animal Parvovirus Vaccine Market by Animal Type (Canine, Feline, Porcine), Vaccine Type (Inactivated, Live Attenuated, Recombinant), Distribution Channel, Product Format, End User - Global Forecast 2025-2030 - Product Image

Animal Parvovirus Vaccine Market by Animal Type (Canine, Feline, Porcine), Vaccine Type (Inactivated, Live Attenuated, Recombinant), Distribution Channel, Product Format, End User - Global Forecast 2025-2030

  • Report
  • 187 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.